ASX - By Stock
|
PYC |
Re:
Ann: Q2 2024 Investor Webinar Presentation
|
|
Timbo57
|
23 |
7.0K |
15 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
23
|
7.0K
|
15
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
Timbo57
|
170 |
75K |
1 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
170
|
75K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Change of Director's Interest Notice
|
|
Timbo57
|
12 |
4.3K |
3 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
12
|
4.3K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call 27 September 2023
|
|
Timbo57
|
20 |
5.9K |
4 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
20
|
5.9K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call 27 September 2023
|
|
Timbo57
|
20 |
5.9K |
9 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
20
|
5.9K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
Price
|
|
Timbo57
|
16 |
5.2K |
8 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
16
|
5.2K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Safety approval VP-001
|
|
Timbo57
|
5 |
2.1K |
3 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
5
|
2.1K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
PYC timelines to revenue
|
|
Timbo57
|
11 |
3.4K |
13 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
11
|
3.4K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
PYC turns 2 corners
|
|
Timbo57
|
44 |
18K |
5 |
16/07/23 |
16/07/23 |
ASX - By Stock
|
44
|
18K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call Advance Notice
|
|
Timbo57
|
22 |
7.9K |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
22
|
7.9K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Valuing PYC
|
|
Timbo57
|
89 |
36K |
17 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
89
|
36K
|
17
|
|
ASX - By Stock
|
PYC |
Re:
Valuing PYC
|
|
Timbo57
|
89 |
36K |
4 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
89
|
36K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Timbo57
|
17 |
4.7K |
1 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
17
|
4.7K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Valuing PYC
|
|
Timbo57
|
89 |
36K |
13 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
89
|
36K
|
13
|
|
ASX - By Stock
|
PYC |
Re:
Ann: FDA Clears PYC to Commence First Human Trials in RP11
|
|
Timbo57
|
90 |
34K |
4 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
90
|
34K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: FDA Clears PYC to Commence First Human Trials in RP11
|
|
Timbo57
|
90 |
34K |
8 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
90
|
34K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: FDA Clears PYC to Commence First Human Trials in RP11
|
|
Timbo57
|
90 |
34K |
5 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
90
|
34K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
The Attractions of PYC's pipeline
|
|
Timbo57
|
38 |
16K |
12 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
38
|
16K
|
12
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Timbo57
|
15 |
6.0K |
0 |
20/11/22 |
20/11/22 |
ASX - By Stock
|
15
|
6.0K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Corporate Presentation - May 2022
|
|
Timbo57
|
59 |
25K |
4 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
59
|
25K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS
|
|
Timbo57
|
103 |
36K |
1 |
26/05/22 |
26/05/22 |
ASX - By Stock
|
103
|
36K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PK STUDY RESULTS MOVE RP11 CLOSER TO FIRST IN HUMAN TRIALS
|
|
Timbo57
|
103 |
36K |
0 |
19/05/22 |
19/05/22 |
ASX - By Stock
|
103
|
36K
|
0
|
|
Charts
|
PYC |
Re:
PYC
|
|
Timbo57
|
78 |
35K |
3 |
21/03/22 |
21/03/22 |
Charts
|
78
|
35K
|
3
|
|
Charts
|
PYC |
Re:
PYC
|
|
Timbo57
|
78 |
35K |
1 |
18/03/22 |
18/03/22 |
Charts
|
78
|
35K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
CNS
|
|
Timbo57
|
49 |
18K |
0 |
23/02/22 |
23/02/22 |
ASX - By Stock
|
49
|
18K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
NICE DAY TODAY
|
|
Timbo57
|
4 |
1.4K |
2 |
19/01/22 |
19/01/22 |
ASX - By Stock
|
4
|
1.4K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Change in substantial holding
|
|
Timbo57
|
60 |
21K |
4 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
60
|
21K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
SP PREDICTION
|
|
Timbo57
|
61 |
28K |
8 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
61
|
28K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Interview with Sue Fletcher PYC CSO
|
|
Timbo57
|
6 |
3.6K |
6 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
6
|
3.6K
|
6
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2021 AGM Chairman's Address and CEO Presentation
|
|
Timbo57
|
63 |
20K |
4 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
63
|
20K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Is this the week?
|
|
Timbo57
|
78 |
23K |
2 |
02/11/21 |
02/11/21 |
ASX - By Stock
|
78
|
23K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Retina Target Engagement Confirmed in Large Eye
|
|
Timbo57
|
94 |
33K |
1 |
29/09/21 |
29/09/21 |
ASX - By Stock
|
94
|
33K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Annual Report to shareholders
|
|
Timbo57
|
17 |
7.0K |
3 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
17
|
7.0K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Quarterly Investor Call - August 17
|
|
Timbo57
|
36 |
10K |
5 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
36
|
10K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of Larger Animal Studies for Lead Program
|
|
Timbo57
|
53 |
17K |
3 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
53
|
17K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of Larger Animal Studies for Lead Program
|
|
Timbo57
|
53 |
17K |
3 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
53
|
17K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Commencement of Larger Animal Studies for Lead Program
|
|
Timbo57
|
53 |
17K |
5 |
14/07/21 |
14/07/21 |
ASX - By Stock
|
53
|
17K
|
5
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Timbo57
|
140K |
53M |
1 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
140K
|
53M
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Larger animal results
|
|
Timbo57
|
7 |
2.9K |
4 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
7
|
2.9K
|
4
|
|
ASX - By Stock
|
PYC |
Progress Updates
|
|
Timbo57
|
10 |
5.3K |
1 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
10
|
5.3K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Timbo57
|
17 |
6.2K |
1 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
17
|
6.2K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Timbo57
|
17 |
6.2K |
5 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
17
|
6.2K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Investor Call - 8am AWST - Wednesday 12 August 2020
|
|
Timbo57
|
16 |
5.6K |
10 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
16
|
5.6K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Shareholder Update - Forward View 2020 Milestones
|
|
Timbo57
|
11 |
4.8K |
1 |
05/08/20 |
05/08/20 |
ASX - By Stock
|
11
|
4.8K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: March 2020 Quarterly Activities and Cash Flow Report
|
|
Timbo57
|
13 |
6.0K |
1 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
13
|
6.0K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Response to ASX Aware Query
|
|
Timbo57
|
12 |
4.8K |
0 |
08/08/19 |
08/08/19 |
ASX - By Stock
|
12
|
4.8K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Response to ASX Aware Query
|
|
Timbo57
|
12 |
4.8K |
3 |
08/08/19 |
08/08/19 |
ASX - By Stock
|
12
|
4.8K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Phylogica's Technology is Effective in Human Cells
|
|
Timbo57
|
36 |
13K |
0 |
07/08/19 |
07/08/19 |
ASX - By Stock
|
36
|
13K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Animal Models - 400% Outperformance of Gold Standard
|
|
Timbo57
|
26 |
6.2K |
5 |
25/07/19 |
25/07/19 |
ASX - By Stock
|
26
|
6.2K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Animal Models - 400% Outperformance of Gold Standard
|
|
Timbo57
|
26 |
6.2K |
3 |
23/07/19 |
23/07/19 |
ASX - By Stock
|
26
|
6.2K
|
3
|
|